{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"23"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"38"}],"units":"Participants"}],"description":"The number of participants who experienced toxicity (defined as at least one grade 3 or higher adverse event at least possibly related to treatment) is reported below.","groups":[{"description":"Lenalidomide: 25mg once daily orally with food on days 1-21 of 28 day cycle until progression or to a maximum of 18 cycles.\n\nDexamethasone: 10-40 mg once weekly (days 1, 8, 15, \\& 22) orally with food until progression.","id":"OG000","title":"Lenalidomide With On-Demand Dexamethasone"}],"paramType":"COUNT_OF_PARTICIPANTS","reportingStatus":"POSTED","timeFrame":"Duration on treatment (up to 18 cycles from registration)","title":"Number of Participants Who Experienced at Least One Grade 3 or Higher Adverse Event at Least Possibly Related to Treatment (Toxicity)","type":"SECONDARY","unitOfMeasure":"Participants"}